AU Patent

AU2022235539A1 — Systems and methods for long term transdermal administration

Assigned to Corium LLC · Expires 2022-10-13 · 4y expired

What this patent protects

Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided. See Fig. 6C.

USPTO Abstract

Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided. See Fig. 6C.

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: AU2022235539A1
Jurisdiction: AU
Classification: —
Expires: 2022-10-13
Drug substance claim: No
Drug product claim: No
Assignee: Corium LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.